trending Market Intelligence /marketintelligence/en/news-insights/trending/XJZe-cyjWx_GJXJrXTqs1g2 content esgSubNav
In This List

Flex Pharma CEO to step down

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Flex Pharma CEO to step down

Flex Pharma Inc. said CEO Christoph Westphal will step down, effective July 3, and remain as board chairman.

The board appointed William McVicar, president of research and development, as interim CEO.